DName-iT (“the Company”) is excited to announce that in December 2024 the EU patent office gave notice of its intention to grant the Company’s 2017 patent EP345 8606, providing important protections for DNamesTM in broad use.
Further good news was received in early January of this year when the US Patent Office also indicated they intend to grant the 2017 patent application 16/302,345.
These developments mark a significant step forward for DName-iT as it continues to expand its intellectual property portfolio and prepares to execute its commercial strategy.
With prior 2017 patent approvals in China, Japan and India, DName-iT is further positioning itself as a leader in the NGS test verification market.
Kevin Dean said, “These patent approvals are a huge step forward for us in further protecting the DNamesTM platform in two of our most important markets for NGS sample preparation. In 2025 will see DName-iT progressing our commercialisation plans, secured by our ever stronger IP.”
Comments